Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5441 Health Center Drive
Abilene, TX 79606Phone+1 325-673-9806Fax+1 325-673-9809- Is this information wrong?
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1992 - 1995
- Texas Health Resources (Dallas)Internship, Internal Medicine, 1991 - 1992
- University of Texas Southwestern Medical SchoolClass of 1991
Certifications & Licensure
- CA State Medical License 1993 - 2026
- TX State Medical License 1997 - 2025
- IL State Medical License 2010 - 2017
- NJ State Medical License 2007 - 2017
- NY State Medical License 1998 - 2017
- OH State Medical License 2007 - 2012
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Pilot Study of X-82 in Patients With Wet AMD Start of enrollment: 2012 Oct 01
- Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 94 citationsEfficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinic...Arshad M. Khanani, Sunil S. Patel, Philip J. Ferrone, Aaron Osborne, Jayashree Sahni
JAMA Ophthalmology. 2020-09-01 - 60 citationsSafety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical...Jayashree Sahni, Pravin U. Dugel, Sunil S. Patel, Mark Chittum, Brian Berger
JAMA Ophthalmology. 2020-09-01 - 43 citationsVisual Function Decline Resulting from Geographic Atrophy Results from the Chroma and Spectri Phase 3 TrialsJeffrey S. Heier, Dante J. Pieramici, Usha Chakravarthy, Sunil S Patel, Sunil Gupta
Ophthalmology. Retina. 2020-01-31
Journal Articles
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationArshad M Khanani, Sunil S Patel, Philip J Ferrone, Pravin U Dugel, JAMA Ophthalmology
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationPravin U Dugel, Sunil S Patel, JAMA Ophthalmology
Authored Content
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Join now to see all
Press Mentions
- Graybug Vision Expands Executive Team with Appointments of Charles P. Semba, MD, and Ward M. Peterson, PhDJune 21st, 2016
Professional Memberships
- Fellow
Hospital Affiliations
- Hendrick Medical CenterAbilene, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: